J. Fenwick

Is backscatter a function-independent method for assessment of treatment response to anti-fibrotic therapy in subclinical diabetic cardiomyopathy? Validation against T1 mapping and collagen biomarkers

J. Sacre, C. Jellis, T. Marwick, 2012 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene.

M. Highley, A. Boddy, J. Lunec, 1999, Seminars in oncology.

Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters

S. Ashley, M. Brada, H. Forbes, 2022 .

Improving outcomes in non-small cell lung cancer; optimum dose fractionation in radical radiotherapy matters.

S. Ashley, M. Brada, H. Forbes, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Estimation of glomerular filtration rate in cancer patients

M. Highley, A. Boddy, A. Calvert, 2001, British Journal of Cancer.

Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy

Jeremy T. Wright, J. Sacre, C. Jellis, 2011, Circulation. Cardiovascular imaging.

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53

C. Rubbi, R. Eccles, D. Sibson, 2010, British Journal of Cancer.

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease

John O'Brien, Robert H. Perry, Mary Johnson, 2003, Journal of Chemical Neuroanatomy.